Search research articles
Contact Us
Filters
Showing results (431-440 of 459) with videos related to
Page
of 46
Sort By:
The Lancet. Haematology
|
December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial
Uwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
Blood Cancer Journal
|
September 22, 2021
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
Nora E Rahmani, Nandini Ramachandra, Srabani Sahu, et al.
Experimental Hematology
|
February 2, 2026
Pyrimethamine overcomes resistance to hypomethylating agents by reducing de-novo pyrimidine synthesis
Bianca Rivera-Peña, Samarpana Chakraborty, Yang Shi, et al.
The Journal of Biological Chemistry
|
May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q
Li Zhou, Joanna Opalinska, Davendra Sohal, et al.
The Journal of Biological Chemistry
|
December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer
Tushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia
Samarpana Chakraborty, Claudia Morganti, Bianca Rivera Pena, et al.
Cell Reports
|
December 13, 2025
Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism
Bryan Harris, Dinesh K Singh, Billy Truong, et al.
Elife
|
October 31, 2019
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Tushar D Bhagat, Dagny Von Ahrens, Meelad Dawlaty, et al.
The Journal of Clinical Investigation
|
January 16, 2026
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome
Madeline Niederkorn, Lavanya Bezavada, Anitria Cotton, et al.
Blood Advances
|
December 6, 2019
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
Ashwin Sridharan, Carolina D Schinke, George Georgiev, et al.
Page
of 46
Search research articles
Search
Showing results (431-440 of 459) with videos related to
Sort By:
Page
of 46
The Lancet. Haematology
|
December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial
Uwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
Blood Cancer Journal
|
September 22, 2021
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
Nora E Rahmani, Nandini Ramachandra, Srabani Sahu, et al.
Experimental Hematology
|
February 2, 2026
Pyrimethamine overcomes resistance to hypomethylating agents by reducing de-novo pyrimidine synthesis
Bianca Rivera-Peña, Samarpana Chakraborty, Yang Shi, et al.
The Journal of Biological Chemistry
|
May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q
Li Zhou, Joanna Opalinska, Davendra Sohal, et al.
The Journal of Biological Chemistry
|
December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer
Tushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia
Samarpana Chakraborty, Claudia Morganti, Bianca Rivera Pena, et al.
Cell Reports
|
December 13, 2025
Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism
Bryan Harris, Dinesh K Singh, Billy Truong, et al.
Elife
|
October 31, 2019
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Tushar D Bhagat, Dagny Von Ahrens, Meelad Dawlaty, et al.
The Journal of Clinical Investigation
|
January 16, 2026
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome
Madeline Niederkorn, Lavanya Bezavada, Anitria Cotton, et al.
Blood Advances
|
December 6, 2019
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
Ashwin Sridharan, Carolina D Schinke, George Georgiev, et al.
Page
of 46